Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001052880 | SCV001217115 | pathogenic | Alagille syndrome due to a JAG1 point mutation | 2019-02-23 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in JAG1 are known to be pathogenic (PMID: 11180599). This variant has not been reported in the literature in individuals with JAG1-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Asp725Glyfs*19) in the JAG1 gene. It is expected to result in an absent or disrupted protein product. |
Fulgent Genetics, |
RCV005029621 | SCV005656299 | likely pathogenic | Alagille syndrome due to a JAG1 point mutation; Tetralogy of Fallot; Deafness, congenital heart defects, and posterior embryotoxon; Charcot-Marie-Tooth disease, axonal, Type 2HH | 2024-01-17 | criteria provided, single submitter | clinical testing |